Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Titel:
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Auteur:
Smith, Matthew R Scher, Howard I Sandhu, Shahneen Efstathiou, Eleni Lara Jr, Primo N Yu, Evan Y George, Daniel J Chi, Kim N Saad, Fred Ståhl, Olof Olmos, David Danila, Daniel C Mason, Gary E Espina, Byron M Zhao, Xin Urtishak, Karen A Francis, Peter Lopez-Gitlitz, Angela Fizazi, Karim